Head of Corporate Strategy
11:25 AM PANEL DISCUSSION: Navigating the Complex Regulatory Landscape from Both Drug and Device Approaches
- Understanding how combination products are defined and classified globally: EU, US and Asia
- Making sense of the regulatory contradictions and focusing on the specific requirements within the EU?
- Gaining a deeper understanding of the roles of Competent Authorities and Notified Bodies
- Post Brexit impacts on drug device combination product regulations